Rob Ruijtenbeek

Activity-based Biomarkers for Precision Medicine

About Dr. Rob Ruijtenbeek

Dr. Rob Ruijtenbeek is Vice President R&D at Pamgene (‘s-Hertogenbosch, The Netherlands), where he heads a multidisciplinary R&D team performing research and development of peptide microarray products and applications in the field of kinases, phosphatases, nuclear receptors and other drug targets. The focus of his current research is the application of peptide microarrays in biomarker discovery in clinical oncology, predicting response to therapy. He is affiliated with the medicinal chemistry and chemical biology group of Utrecht University, where new applications for the peptide microarray technology are investigated in the area of pharmaceutical research & development. This has resulted in multiple scientific publications, patent applications and commercialized products.

Rob Ruijtenbeek holds a M.Sc. degree in both biochemistry and organic chemistry from the University of Nijmegen (1996) and received his Ph.D. degree in 2001 at the faculty of Pharmacy of the University of Utrecht, The Netherlands.

www.pamgene.com

me